NA
IRMD icon

Navellier & Associates’s iRadimed IRMD Stock Holding History

Navellier & Associates’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,296
Closed -$263K – 287
2022
Q4 		$263K Buy
9,296
+1,045
+13% +$29.9K 0.05% 226
2022
Q3 		$248K Sell
8,251
-61
-0.7% -$2.13K 0.06% 236
2022
Q2 		$282K Sell
8,312
-73
-0.9% -$2.62K 0.06% 236
2022
Q1 		$376K Buy
8,385
+123
+1% +$5.69K 0.06% 235
2021
Q4 		$382K Buy
+8,262
New +$333K 0.06% 243
2020
Q2 		– Sell
-20,800
Closed -$444K – 257
2020
Q1 		$444K Hold
20,800
– – 0.1% 147
2019
Q4 		$486K Sell
20,800
-7,532
-27% -$176K 0.08% 182
2019
Q3 		$596K Sell
28,332
-103,395
-78% -$2.11M 0.1% 166
2019
Q2 		$2.69M Buy
131,727
+8,289
+7% +$195K 0.42% 62
2019
Q1 		$3.47M Buy
123,438
+6,727
+6% +$176K 0.54% 44
2018
Q4 		$2.85M Buy
116,711
+23,127
+25% +$621K 0.49% 44
2018
Q3 		$3.48M Buy
+93,584
New +$2.53M 0.45% 63
2016
Q3 		– Sell
-10,000
Closed -$218K – 296
2016
Q2 		$218K Sell
10,000
-922
-8% -$16.6K 0.03% 220
2016
Q1 		$209K Buy
10,922
+108
+1% +$2.07K 0.03% 195
2015
Q4 		$303K Buy
+10,814
New +$306K 0.03% 168

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Navellier & Associates's IRMD Position: Q1 2023 in Review

Navellier & Associates sold out of iRadimed (IRMD) in Q1 2023, closing a stake of 9,296 shares — an estimated $263K sold.

Navellier & Associates first reported a position in IRMD in Q4 2015 and held it in 15 quarters. The position peaked at $3.48M in Q3 2018. 89 funds tracked by Wall St. Rank hold IRMD as of Q1 2023.

  • Navellier & Associates reported no remaining iRadimed position as of Q1 2023 after selling out during the quarter.
  • Navellier & Associates sold 9,296 iRadimed shares in Q1 2023, an estimated $263K.
  • Navellier & Associates first reported a position in iRadimed in Q4 2015 and held it in 15 quarters.
  • Navellier & Associates's iRadimed position peaked at $3.48M in Q3 2018.
  • 89 funds tracked by Wall St. Rank held iRadimed as of Q1 2023.

Based on Navellier & Associates's 13F filing for Q1 2023, filed 12 May 2023.